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The importance of the umbilical cord
 The umbilical cord is not only tissue, but a whole organ connecting 
mother and fetus. It develops from and contains remnants of 
the yolk sac and allantois, and is therefore derived from 
the zygote.
 The cord is not directly connected to the mother's circulatory 
system, but instead joins the placenta, which transfers materials to 
and from the mother's blood without allowing direct mixing. 
 The cellular component of umbilical cord blood (UCB) is primarily 
comprised of lymphocytes and monocytes. It has a comparable B-
lymphocyte population and a lower absolute number of T-
lymphocytes. 
Challenges for cord blood investigation
 Many of the UCB features can be used for research and 
therapeutic purposes. After the delivery, umbilical cord 
is completely out of any function, therefore it can be 
discarded.
 It is the least harmful intervention, and at the same 
time extremely unexplored tissue
 Last decade the interest for the umbilical cord blood is 
growing with an extremely pace. The explanation 
comes from different perspectives.
Placenta and umbilical cord
Biochemical value
 The blood for the first neonatal analyses can be drawn 
without any harm to the baby, thus enabling the 
neonatologist investigating blood gasses, full blood 
count, bilirubin, etc.
 Delayed cord clamping can prevent from anemia of 
prematurity and improve the health status of the 
premature newborns.
Umbilical cord blood
Genetic testing
 From 24 to 34 weeks of gestation, when the fetus is 
typically viable, blood can be taken from the cord in order 
to test for abnormalities (particularly for 
hereditary conditions). 
 This diagnostic genetic at hereditary procedure procedure 
is known as percutaneous umbilical cord blood sampling.
 Immunological analysis can be performed for determination 
of the blood group, Rhesus factor, and other immunological 
investigations.
Central vessel approach - Therapeutical value
 Catheterization of the cord blood vessels is the best way to reach 
neonatal circulation, i.e. the umbilical vein is directly connected 
to the central circulation, so it can be used as a route for 
placement of a venous catheter for infusion and medication, 
applying medication, even during resuscitation, and performing 
blood exchange in hemolytic disease of the newborn. 
 The umbilical vein catheter is a reliable alternative to 
percutaneous peripheral or central venous catheters and may be 
employed in resuscitation or intensive care of the newborn. 
Umbilical arteries can be used for taking blood for analysis, 
measuring directly blood pressure.
 Catheterization of the both blood vessels, artery and vein, 
enables long term monitoring of the homeostasis, and 
administration of the drugs. It serves as a central vein.
Content of the umbilical cord
Cord blood banking
 Umbilical cord blood banking has become a new obstetrical 
trend. It offers expectant parents a biological insurance policy 
that can be used in the event of a child or family member’s life-
threatening illness and puts patients in a position of control over 
their own treatment options. 
 It means that the UCB, a once discarded material, is an organ 
that could be transplanted to either oneself or to another 
recipient. Such complicated treatment is possible due to some 
properties of the UCB.
Properties of the umbilical cord blood
 relative immaturity compared to adult cell sources, having higher 
proportion of immature T-lymphocytes and decreased numbers of 
mature memory T-lymphocytes UCB cells also produce fewer 
absolute levels of cytokines than adult cell sources. This lack of 
mature immune function is attributed to UCB’s low incidence of Graft 
versus Host Disease (GvHD) and viral transmission. Such cellular 
constitution could allow for less stringent donor–recipient matching 
requirements, hence leading to shorter waiting period for treatment.
 contains a large population of hematopoietic stem/progenitor cells 
compared to adult sources. These easily procured, low immunogenic 
sources of multipotential cells are thought to have the capability to 
become any type of cell in the body under specific conditions.
Properties of the umbilical cord blood-ctd.
 non-hematopoietic stem cell, the mesenchymal stem cell (MSC), 
has also been found in UCB in much lower numbers than in bone 
marrow. The MSC can give rise to such diverse phenotypes as 
osteoblasts, chondroblasts, adipocytes, and hematopoietic and 
neural cells (astrocytes and neurons) because they are 
multipotent. 
 Identification of this cell population is challenging because it 
currently lacks a definitive phenotype as well as agreement on 
exactly which surface antigens designate this cell. 
 The blood within the umbilical cord, is a rich and readily available 
source of primitive, undifferentiated stem cells. 
Advantages of UCB in treatment of leukemia
 The advantages of the UCB compared to bone marrow in 
treatment of leukemia and other diseases mainly are the 
following: no risk or discomfort to donors, lower incidence of 
viral contamination (38.2%) compared to BM, able to be stored 
at cryogenic temperatures indefinitely without significantly 
affecting cell viability, immediately available and easily shipped 
and many others.
 There is a high immune tolerance of UCB cells because they are 
unable to generate cytotoxic T-Lymphocytes, which respond to 
allogenic antigens.
Potential for replacement of dead cells
 Current research shows some potential therapeutic effects as the 
ideal source of cells used for replacement of dead and/or 
diseased cells in a number of injuries and diseases. In vivo 
research has found that human UCB can ameliorate behavioral 
and physiological consequences in a number of animal disease 
models, the most exciting of which included diseases and injury 
of the brain. The most recent researches on animals have 
demonstrated UCB’s growth as a multidimensional treatment, 
mostly as a neurotrophic, neuroprotective, and anti-
inflammatory agent.
Potential for replacement of dead cells
Disadvantages of the UCB
 But, besides many advantages, there are some hazardous effects 
of the UBC. In multiple American and international 
studies, cancer-causing chemicals have been found in the blood 
of umbilical cords. These originate from certain plastics, 
computer circuit boards, fumes and synthetic fragrances among 
others. Over 300 toxic chemicals have been found, 
including bisphenol A, tetrabromobisphenol A, teflon-related 
perfluorooctanoic acid, galaxolide and many other air pollutants 
among others.
Conclusions 
 As a summary, the UCB has some clinical uses in many rare 
diseases and in the treatment of malignant diseases and dead cells 
and tissues, has advantages against bone marrow transplantation, 
can be used for many testing, and although there are some toxic 
effects, still the benefit overweighs the damage.
 But, what are the other possibilities of the use of the UCB? The 
research will never come to its end, because the umbilical cord is 
one of the most unexplored organ, and on the other hand, the 
most harmless target organ for research.

